Skip to Main Content

Author Details

Phuong Nguyen
Hoag Memorial Hospital Presbyterian
1983
334
57
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37989888The hospital frailty risk score as a predictor of readmission after ERCP.Surg Endosc2024
37989888The hospital frailty risk score as a predictor of readmission after ERCP.Surg Endosc2024
36331566Co-mutational pattern of somatic GATA2-mutated myeloid neoplasms.Ann Hematol2023
35442101"It's Like You Stuck a Pin in It:" African American/Black Patients Describe Cutaneous Toxicity From Epidermal Growth Factor Receptor Inhibitors.Am J Hosp Palliat Care2023
36331566Co-mutational pattern of somatic GATA2-mutated myeloid neoplasms.Ann Hematol2023
35727176In vitro and in silico antioxidant and α-glucosidase inhibitory potential of compounds isolated from <i>Garcinia gaudichaudii</i>.Nat Prod Res2023
37032414Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.Blood Cancer J2023
37086467εγ-Thalassemia, a New Hemoglobinopathy Category.Clin Chem2023
36477202Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience.Blood Adv2023
36918226CD47 expression is critical for CAR T-cell survival in vivo.J Immunother Cancer2023
35442101"It's Like You Stuck a Pin in It:" African American/Black Patients Describe Cutaneous Toxicity From Epidermal Growth Factor Receptor Inhibitors.Am J Hosp Palliat Care2023
35727176In vitro and in silico antioxidant and α-glucosidase inhibitory potential of compounds isolated from <i>Garcinia gaudichaudii</i>.Nat Prod Res2023
37086467εγ-Thalassemia, a New Hemoglobinopathy Category.Clin Chem2023
37032414Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.Blood Cancer J2023
36477202Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience.Blood Adv2023
36918226CD47 expression is critical for CAR T-cell survival in vivo.J Immunother Cancer2023
34396792Predictive Factors for Velopharyngeal Insufficiency Following Primary Cleft Palate Repair.Cleft Palate Craniofac J2022
36037623Comparison between GATA2 and DDX41-mutated myeloid neoplasms.Leuk Res2022
36224601Transcriptomic profiling of sporadic Alzheimer's disease patients.Mol Brain2022
35939636Informed Consent Practices in Global Surgery among Plastic Surgery Organizations.Plast Reconstr Surg2022
35938646Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined Significance.Am J Clin Pathol2022
35860034Modular micro-PCR system for the onsite rapid diagnosis of COVID-19.Microsyst Nanoeng2022
36427906Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity.J Immunother Cancer2022
36184685Autoimmune manifestations in STAG2-mutated myeloid neoplasms.Ann Hematol2022
34519705Where Are We Headed? Diagnosing Abnormal Head Shapes Through Virtual Care Visits.J Craniofac Surg2022
35261937Association of Physician Referrals with Timely Cancer Care Using Tumor Registry and Claims Data.Health Equity2022
34396792Predictive Factors for Velopharyngeal Insufficiency Following Primary Cleft Palate Repair.Cleft Palate Craniofac J2022
34728162Pharmacist monitoring of direct oral anticoagulants for American Indians and Alaska Natives in the outpatient setting.J Am Pharm Assoc (2003)2022
35232696Understanding "Patient refuses" among 90+ year old patients with cancer or presumed cancer.J Geriatr Oncol2022
35078980Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series.Blood Cancer J2022
35078969Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients.Blood Cancer J2022
34644397Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms.Blood Adv2022
35052621Induction of Paraptotic Cell Death in Breast Cancer Cells by a Novel Pyrazolo[3,4-<i>h</i>]quinoline Derivative through ROS Production and Endoplasmic Reticulum Stress.Antioxidants (Basel)2022
34995873Personal history of autoimmune disease and other medical conditions and risk of myelodysplastic syndromes.Cancer Epidemiol2022
34873100Socioeconomic Factors Impact the Timing of Surgical Repair for Craniosynostosis - A Regional and National Assessment.J Craniofac Surg2022
35860034Modular micro-PCR system for the onsite rapid diagnosis of COVID-19.Microsyst Nanoeng2022
36427906Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity.J Immunother Cancer2022
35939636Informed Consent Practices in Global Surgery among Plastic Surgery Organizations.Plast Reconstr Surg2022
35938646Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined Significance.Am J Clin Pathol2022
36037623Comparison between GATA2 and DDX41-mutated myeloid neoplasms.Leuk Res2022
36224601Transcriptomic profiling of sporadic Alzheimer's disease patients.Mol Brain2022
36184685Autoimmune manifestations in STAG2-mutated myeloid neoplasms.Ann Hematol2022
34995873Personal history of autoimmune disease and other medical conditions and risk of myelodysplastic syndromes.Cancer Epidemiol2022
34873100Socioeconomic Factors Impact the Timing of Surgical Repair for Craniosynostosis - A Regional and National Assessment.J Craniofac Surg2022
35052621Induction of Paraptotic Cell Death in Breast Cancer Cells by a Novel Pyrazolo[3,4-<i>h</i>]quinoline Derivative through ROS Production and Endoplasmic Reticulum Stress.Antioxidants (Basel)2022
35232696Understanding "Patient refuses" among 90+ year old patients with cancer or presumed cancer.J Geriatr Oncol2022
35261937Association of Physician Referrals with Timely Cancer Care Using Tumor Registry and Claims Data.Health Equity2022
35078980Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series.Blood Cancer J2022
35078969Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients.Blood Cancer J2022
34644397Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms.Blood Adv2022
  • 1 - 50 of 668

Recommended Authors

Christopher Szeto
La Trobe Institute for Molecular Science, La Trobe University
Career Start Year 2005
Number of shared co-authors 2
Ke Jin
West China Hospital, Sichuan University
Career Start Year 2005
Number of shared co-authors 1
Dexiang Gao
University of Colorado Anschutz Medical Campus
Career Start Year 2001
Number of shared co-authors 0
Deng Pan
College of Plant Protection, Southwest University
Career Start Year 2001
Number of shared co-authors 0
Melita Irving
Guy's and St Thomas' NHS Foundation Trust, Evelina Children's Hospital
Career Start Year 2001
Number of shared co-authors 2
Soledad Fernandez
McGill University
Career Start Year 2001
Number of shared co-authors 3
Mi-Ok Kim
University of California san francisco
Career Start Year 2000
Number of shared co-authors 6
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 1
Vivian Lee
Keck School of Medicine of USC, University of Southern
Career Start Year 1999
Number of shared co-authors 0
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 1
Sunil K Joshi
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 1
Rong Fan
Institute of Pathogens and Vectors, Dali University
Career Start Year 1998
Number of shared co-authors 0
Ji Eun Oh
College of Science & Industry Convergence, Ewha Womans University
Career Start Year 1997
Number of shared co-authors 0
Chun-Liang Chen
National Dong Hwa University
Career Start Year 1997
Number of shared co-authors 0
David Elashoff
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 3
Eun Young Kim
College of Korean Medicine, Kyung Hee University
Career Start Year 1995
Number of shared co-authors 3
Manish J Butte
University of California Los Angeles
Career Start Year 1994
Number of shared co-authors 2
Huy Nguyen
The University of Danang-University of Science and Technology
Career Start Year 1993
Number of shared co-authors 4
Jenny Xiang
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 0
Dong Wook Kim
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Career Start Year 1992
Number of shared co-authors 0
Borko Jovanovic
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 1
Motomi Mori
St Jude Children's Research Hospital.
Career Start Year 1988
Number of shared co-authors 4
Peter W Marks
Center for Biologics Evaluation and Research
Career Start Year 1988
Number of shared co-authors 2
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Paula K Roberson
and Clinical Center, Central Arkansas Veterans Healthcare System
Career Start Year 1984
Number of shared co-authors 0
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 2
Robert E Lewis
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 1
Stephen E Kurtz
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 1979
Number of shared co-authors 1
Hiroshi Handa
Center for Future Medical Research, Tokyo Medical University
Career Start Year 1975
Number of shared co-authors 1
Judith D Goldberg
NYU Grossman School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Steven L Wagner
Co-authored papers 16
Naseema Gangat
Mayo Clinic
Co-authored papers 16
Jenny N Poynter
University of Minnesota
Co-authored papers 11
Robert J Fletterick
University of California San Francisco
Co-authored papers 9
Rudolph E Tanzi
Co-authored papers 8
William C Mobley
University of California San Diego
Co-authored papers 7
Kevin D Rynearson
Co-authored papers 6
Jeff A Sloan
Mayo Clinic
Co-authored papers 4
Cheng Cheng
St. Jude Children's Research Hospital
Co-authored papers 4
Yi Zheng
Children's Hospital Research Foundation
Co-authored papers 4
Kun Guo
Co-authored papers 4
Charles W M Roberts
Co-authored papers 3
Shondra M Pruett-Miller
St. Jude Children's Research Hospital.
Co-authored papers 3
Can Zhang
Co-authored papers 3
Philip C Wong
Co-authored papers 2
Scott A Lesley
Merck & Co., Inc.
Co-authored papers 2
Charles L Loprinzi
Mayo Clinic
Co-authored papers 2
Anang A Shelat
St. Jude Children's Research Hospital
Co-authored papers 2
Peter J Park
Harvard Medical School
Co-authored papers 2
Yue-Ming Li
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Carol M Anderson
University of California san francisco
Co-authored papers 2
Bruce R Conklin
Gladstone Institutes
Co-authored papers 2
Daniela Boassa
University of California San Diego
Co-authored papers 2
Marc-Andr?? Elsliger
Joint Center for Structural Genomics
Co-authored papers 2
Eric W Klee
Mayo Clinic College of Medicine and Science
Co-authored papers 2
David A Agard
University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Co-authored papers 2
Ian A Wilson
The Scripps Research Institute, USA The Skaggs Institute for Chemical Biology
Co-authored papers 2
Carol L Farr
Joint Center for Structural Genomics
Co-authored papers 2
Carmen Radecki Breitkopf
Mayo Clinic
Co-authored papers 2
Ashley M Deacon
Accelero Biostructures Inc., USA XPose Therapeutics Inc.
Co-authored papers 2
Release 1.2